SEC Info - Third Point LLC, et al. - ‘SC 13D’ on 5/17/07 re: CV Therapeutics Inc

SEC Info℠

Home

Help

Please Sign In

Third Point LLC, et al. – ‘SC 13D’ on 5/17/07 re: CV Therapeutics Inc

On: Thursday, 5/17/07, at 1:58pm ET · Accession #: 899140-7-997 · File #: 5-47551

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/17/07  Third Point LLC                   SC 13D                 3:37K  CV Therapeutics Inc               Willkie Fa… Gallagher/FA
          Daniel S. Loeb
          Third Point Offshore Fund, Ltd.

General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership             15     54K 
 2: EX-99.1     Joint Filing Agreement                                 1      7K 
 3: EX-99.2     Power of Attorney                                      2     10K

Filing Submission 0000899140-07-000997 – SGML Text

Original SGML Text submitted by:	Willkie Farr & Gallagher (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Third Point LLC, et al. – ‘SC 13D’ on 5/17/07 re: CV Therapeutics Inc

On: Thursday, 5/17/07, at 1:58pm ET · Accession #: 899140-7-997 · File #: 5-47551

Previous ‘SC 13D’: ‘SC 13D/A’ on 5/11/07 · Next: ‘SC 13D/A’ on 5/22/07 · Latest: ‘SC 13D’ on 2/13/24

General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

To view the SGML, please refresh this page.

General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

To view the SGML, please refresh
this page.